Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:44:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this internal version change does not alter user-facing content or functionality.
    Difference
    0.1%
    Check dated 2026-02-04T22:57:48.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New: Show glossary toggle, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T19:59:23.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no substantive changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:55:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A top-level Locations section was added listing California, Massachusetts, New York, North Carolina, Texas, and Utah. The previous per-state location subsections (California Locations, Massachusetts Locations, New York Locations, North Carolina Locations, Texas Locations, Utah Locations) were removed.
    Difference
    0.7%
    Check dated 2025-12-23T21:28:16.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Publications now indicate that PubMed entries are automatically filled in from PubMed and may not relate to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:20:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.